p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: Correlation with human papillomavirus detection

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 9, 2007, Pages 1343-1349

  Iaconis, Lori ^a   Hyjek, Elizabeth ^b   Ellenson, Lora H ^b   Pirog, Edyta C ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; PROTEIN P16INK4A;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOCHEMISTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL METAPLASIA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX MUCOSA; VIRUS DETECTION; WART VIRUS; ADOLESCENT; AGED; CASE CONTROL STUDY; CLASSIFICATION; GENETICS; METABOLISM; METAPLASIA; MIDDLE AGED; MUCOSA; PATHOLOGY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; KI-67 ANTIGEN; METAPLASIA; MIDDLE AGED; MUCOUS MEMBRANE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 34548736601     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Crum CP, Egawa K, Fu YS, et al. Atypical immature metaplasia (AIM): a subset of human papilloma virus infection of the cervix. Cancer. 1983;51:2214-2219.
2. Park JJ, Genest DR, Sun D, Crum CP. Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. Hum Pathol. 1999;10:1161-1165.
3. Geng L, Connolly DC, Isacson C, Ronnett BM, Cho KR. Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol. 1999;30:345-351.
4. Pirog EC, Chen YT, Isacson C. MIB-1 immunostaining is a beneficial adjunct test for the accurate diagnosis of vulvar condyloma acuminatum. Am J Surg Pathol. 2000;24:1393-1399.
5. Pirog EC, Baergen RN, Soslow RA, et al. Diagnostic accuracy of cervical low grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol. 2001;26:70-75.
6. Logani S, Lu D, Quint W, Ellenson L, Pirog EC. Low grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol. 2003;16:735-741.
7. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A. 1996;93:4350-4354.
8. Serrano M. The tumor suppressor protein p16INK4a. Exp Cell Res. 1997;237:7-13.
9. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741-1748.
10. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
11. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004;35:689-696.
12. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol. 2006;19:384-391.
13. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891.
14. Wang SS, Trunk M, Schiffman M, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004;13:1355-1360.
15. Hu L, Guo M, He Z, et al. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol. 2005;18:267-273.
16. Shiozawa T, Nikaido T, Shimizu M, Zhai Y, Fujii S. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma. Cancer. 1997;80:2250-2256.
17. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer; 2002:283.
18. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477.
19. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153:1731-1739.
20. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999;37:2508-2517.
21. http://www.mtm-laboratories.com/.
22. Duggan MA, Akbari M, Magliocco AT. Atypical immature metaplasia: longitudinal follow up and outcome predictors. Presented at: 95th Annual Meeting of the United States and Canadian Academy of Pathology; February 13, 2006; Atlanta, Ga. Abstract 816.
23. Duggan MA, Magliocco AT. Atypical immature metaplasia: p16 immunoprofiling. Presented at: 94th Annual Meeting of the United States and Canadian Academy of Pathology; February 28, 2005; San Antonio, Tex. Abstract 841.
24. Qiao X, Bhuiya TA, Spitzer M. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis. 2005;9:100-107.
25. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186-192.
26. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92:727-735.
27. Trimble CL, Piantadosi S, Gravitt P, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res. 2005;11:4717-4723.
28. Baak JP, Kruse AJ, Garland SM, et al. Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions. Am J Surg Pathol. 2005;29:1062-1066.